Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 12, 882 - 884 (2006)
doi:10.1038/nm0806-882
Embryogenesis meets tumorigenesis
John T Lee1 & Meenhard Herlyn1
- The authors are in the Program of Molecular & Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. e-mail: herlynm@wistar.org
Abstract
Transplantation of metastatic melanoma cells into zebrafish embryo disrupts development—and identifies a potential new drug target for this deadly cancer (pages 925–932).
Metastatic melanoma remains one of the deadliest diseases, with a 5-year survival rate of less than 20%. The identification of new biological mediators of disease is the most rational approach to developing drugs to shift these dismal odds.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo ? use of the human tyrosinase promoter with human enhancersCancer Gene Therapy Original Article
p38 Mitogen-Activated Protein Kinase Inhibitor Protects the Epidermis Against the Acute Damaging Effects of Ultraviolet Irradiation by Blocking Apoptosis and Inflammatory ResponsesJournal of Investigative Dermatology Original Article
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressivenessNature Medicine Article (01 Aug 2006)
See all 4 matches for Research